we lead the way in bio || intelligence for a sustainable future
our history
Born from an INSERM (French National Institute of Health and Medical Research) spin-off, Spartha Medical leads the way in bio||intelligence, combining expertise in biomaterials and bioengineering to push the boundaries of health protection
Guided by our mission to preserve health naturally and protect lives, we harness the power of nature to develop innovative, sustainable solutions that align with the principles of One Health—ensuring a positive impact on human, animal, and environmental well-being
our milestones
CIR approval for research and development
EIC Accelerator granted
our founders
executive board
strategic advisory board
clinical and scientific advisory board
collaborative projects
TOXBOX exemplifies our commitment to safety and sustainability. With 16 partners from 9 countries, this project focuses on developing an instrument to provide reliable toxicity data for chemicals under relevant conditions, promoting safer and more sustainable practices in chemical monitoring.
As the scientific coordinator, Spartha Medical is at the forefront of promoting the « Safe and Sustainable by Design » approach, ensuring that innovations in materials science align with global environmental goals.
In partnership with 13 collaborators from 7 countries, NET4MAT is an ambitious initiative to revolutionize food packaging.
This project aims to develop antimicrobial biodegradable plastics that enhance food safety, extend shelf life, and reduce environmental impact. The project’s outcomes promise to benefit both consumers and the environment.
Bio-Tune, which included 6 European partners and 4 international collaborators, focused on developing multifunctional coatings for medical devices.
Completed in 2024, the project demonstrated the versatility of our technology in improving the safety and effectiveness of medical implants. The knowledge and results gained continue to inspire new developments in healthcare applications.
KISSMat brings together 3 partners from the Grand Est region in a focused effort to identify new antimicrobial solutions for the medical, cosmetic, and food sectors.
This project emphasizes the adaptability of our technology across diverse applications, highlighting its potential to address global challenges in health, hygiene, and food safety.
social responsibility
Since its creation, Spartha Medical has strived to make a positive impact, both within its organization and beyond. By integrating Corporate Social Responsibility (CSR) from the earliest stages of the company’s development, we formalize our commitment to integrating social and environmental criteria into our business activity and strategic vision.
Spartha Medical supports the Sustainable Development Goals
Our commitments are based on and aligned with the 17 Sustainable Development Goals (SDGs) presented by the United Nations with the Agenda 2030.
gender equality
Gender Equality is also an SDG to which we are aligned and reflects our values, with the aim of promoting a professional culture based on respect and inclusion. We have created a Gender Equality Plan (GEP) to formalize our commitment to this goal.
With this document, we are aligning ourselves with European expectations in this area.
Download the PDF here
European Innovation Council
Funded by the European Union. The views and opinions expressed are those of the authors and do not necessarily reflect those of the European Union or SPARTHA Medical. Neither the European Union nor the granting authority can be held responsible for them.
